Literature DB >> 24294046

Relationship between serum uric acid levels and ventricular function in patients with idiopathic pulmonary hypertension.

Chun-Yan Zhang1, Long-Le Ma, Le-Xin Wang.   

Abstract

OBJECTIVE: To investigate the relationship between serum uric acid levels and pulmonary hypertension in patients with idiopathic pulmonary artery hypertension (IPAH).
METHODS: Serum uric acid levels were measured in 86 patients (mean [± SD] age 35.2±12.3 years; 36 men) with IPAH. Pulmonary arterial pressure and ventricular function were assessed using echocardiography. Serum uric acid levels were also measured in 40 healthy subjects (35.9±11.6 years of age; 15 men).
RESULTS: Serum uric acid levels in IPAH patients were higher compared with control subjects (405±130 μmol/L versus 344±96 μmol/L; P<0.05). Fifty-two (60.4%) of the 86 patients with IPAH had elevated serum uric acid levels. The pulmonary systolic pressure and mean pulmonary pressure in the high uric acid group were higher than in the normal uric acid group (P<0.05). The left and right ventricular ejection fractions were lower in the high uric acid group compared with the normal uric acid group (P<0.05). Serum uric acid levels were correlated with the mean pulmonary arterial pressure (r=0.387; P<0.01) and New York Heart Association class (r=0.41; P<0.01). There was also an inverse correlation between uric acid levels and the left (r=-0.550; P<0.01) and right ventricular ejection fractions (r=-0.481; P<0.05).
CONCLUSION: Serum uric acid levels are associated with IPAH severity and the severity of ventricular dysfunction.

Entities:  

Keywords:  Idiopathic pulmonary artery hypertension; Uric acid; Ventricular function

Year:  2013        PMID: 24294046      PMCID: PMC3716500     

Source DB:  PubMed          Journal:  Exp Clin Cardiol        ISSN: 1205-6626


  15 in total

1.  Hyperuricemia in severe pulmonary hypertension.

Authors:  M A Voelkel; K M Wynne; D B Badesch; B M Groves; N F Voelkel
Journal:  Chest       Date:  2000-01       Impact factor: 9.410

2.  Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study.

Authors:  B F Culleton; M G Larson; W B Kannel; D Levy
Journal:  Ann Intern Med       Date:  1999-07-06       Impact factor: 25.391

3.  Serum uric acid levels correlate with the severity and the mortality of primary pulmonary hypertension.

Authors:  N Nagaya; M Uematsu; T Satoh; S Kyotani; F Sakamaki; N Nakanishi; M Yamagishi; T Kunieda; K Miyatake
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

4.  Hyperuricemia induces endothelial dysfunction.

Authors:  Uday M Khosla; Sergey Zharikov; Jennifer L Finch; Takahiko Nakagawa; Carlos Roncal; Wei Mu; Karina Krotova; Edward R Block; Sharma Prabhakar; Richard J Johnson
Journal:  Kidney Int       Date:  2005-05       Impact factor: 10.612

5.  Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging.

Authors:  Stefan D Anker; Wolfram Doehner; Mathias Rauchhaus; Rakesh Sharma; Darrel Francis; Christoph Knosalla; Constantinos H Davos; Mariantonietta Cicoira; Waqar Shamim; Michel Kemp; Robert Segal; Karl Josef Osterziel; Francisco Leyva; Roland Hetzer; Piotr Ponikowski; Andrew J S Coats
Journal:  Circulation       Date:  2003-04-21       Impact factor: 29.690

6.  Hyperuricemia as a prognostic factor in pulmonary arterial hypertension.

Authors:  D Bendayan; D Shitrit; M Ygla; M Huerta; G Fink; M R Kramer
Journal:  Respir Med       Date:  2003-02       Impact factor: 3.415

7.  Haemodynamic correlates and prognostic significance of serum uric acid in adult patients with Eisenmenger syndrome.

Authors:  H Oya; N Nagaya; T Satoh; F Sakamaki; S Kyotani; M Fujita; N Nakanishi; K Miyatake
Journal:  Heart       Date:  2000-07       Impact factor: 5.994

8.  Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells.

Authors:  Sergey Zharikov; Karina Krotova; Hanbo Hu; Chris Baylis; Richard J Johnson; Edward R Block; Jawaharlal Patel
Journal:  Am J Physiol Cell Physiol       Date:  2008-09-10       Impact factor: 4.249

9.  Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

10.  Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk.

Authors:  Giuseppe Mercuro; Cristiana Vitale; Elena Cerquetani; Sandra Zoncu; Martino Deidda; Massimo Fini; Giuseppe M C Rosano
Journal:  Am J Cardiol       Date:  2004-10-01       Impact factor: 2.778

View more
  10 in total

1.  Diagnosis of chronic heart failure by the soluble suppression of tumorigenicity 2 and N-terminal pro-brain natriuretic peptide.

Authors:  Xiao-Ling Jin; Ning Huang; Hui Shang; Ming-Cheng Zhou; Yi Hong; Wen-Zheng Cai; Jie Huang
Journal:  J Clin Lab Anal       Date:  2017-07-18       Impact factor: 2.352

2.  Long-Term Survival of Patients with Pulmonary Arterial Hypertension at a Single Center in Taiwan.

Authors:  Le-Yung Wang; Kuang-Tso Lee; Chia-Pin Lin; Lung-An Hsu; Chun-Li Wang; Tsu-Shiu Hsu; Wan-Jing Ho
Journal:  Acta Cardiol Sin       Date:  2017-09       Impact factor: 2.672

3.  Polychlorinated Biphenyls and Pulmonary Hypertension.

Authors:  Hamza Assaggaf; Changwon Yoo; Roberto G Lucchini; Steven M Black; Munerah Hamed; Faisal Minshawi; Quentin Felty
Journal:  Int J Environ Res Public Health       Date:  2022-04-13       Impact factor: 4.614

4.  Altered Gut Microbiome Profile in Patients With Pulmonary Arterial Hypertension.

Authors:  Seungbum Kim; Katya Rigatto; Marcelo B Gazzana; Marli M Knorst; Elaine M Richards; Carl J Pepine; Mohan K Raizada
Journal:  Hypertension       Date:  2020-02-24       Impact factor: 10.190

5.  Clinical and hemodynamic profiles of elderly patients with pulmonary arterial hypertension: a single center, prospective study.

Authors:  Ebru Ozpelit; Bahri Akdeniz; Dilek Sezgin; Can Sevinc; Kemal Can Tertemiz; Mehmet Emre Ozpelit; Mustafa Baris; Nezihi Baris
Journal:  J Geriatr Cardiol       Date:  2017-01       Impact factor: 3.327

6.  Relationship between Serum Uric Acid Levels and the Severity of Pulmonary Hypertension.

Authors:  Seyyed Reza Seyyedi; Majid Malekmohammad; Mandana Chitsazan; Neda Behzadnia; Makan Sadr; Seyed Mohammadreza Hashemian; Babak Sharif-Kashani
Journal:  Tanaffos       Date:  2017-06

7.  Screening strategies for pulmonary arterial hypertension.

Authors:  David G Kiely; Allan Lawrie; Marc Humbert
Journal:  Eur Heart J Suppl       Date:  2019-12-17       Impact factor: 1.803

8.  Serum uric acid is associated with disease severity and may predict clinical outcome in patients of pulmonary arterial hypertension secondary to connective tissue disease in Chinese: a single-center retrospective study.

Authors:  Jingya Wang; Yuanyuan Wang; Xiaodi Li; Yingheng Huang; Xiaoxuan Sun; Qiang Wang; Miaojia Zhang
Journal:  BMC Pulm Med       Date:  2020-10-19       Impact factor: 3.317

Review 9.  Negative Effects of Chronic High Intake of Fructose on Lung Diseases.

Authors:  Adrián Hernández-Díazcouder; Javier González-Ramírez; Fausto Sanchez; José J Leija-Martínez; Gustavo Martínez-Coronilla; Luis M Amezcua-Guerra; Fausto Sánchez-Muñoz
Journal:  Nutrients       Date:  2022-10-01       Impact factor: 6.706

10.  Evaluation of serum uric acid level in systemic lupus erythematosus patients with normal and high pulmonary arterial hypertension.

Authors:  Miramir Aghdashi; Mahsa Behnemoon; Jila Mahmoodi Rad; Masoumeh Rabiepour
Journal:  Biomedicine (Taipei)       Date:  2018-08-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.